Compugen CGEN 深 滬
等待開盤 12-12 09:30:00 美东时间
1.60
-0.030
-1.84%
華盛通- 最 高1.665
- 今 開1.62
- 成交量 14.95万股
- 最 低 1.59
- 昨 收 1.63
- 總市值 1.50亿
- 52周最高 2.66
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.13
- 委 比 77.45%
- 總股本 9353.54万
- 歷史最高 19.90
- 量 比 0.43
- 振 幅 4.60%
- 歷史最低 0.51
- 每 手 1
- 風險率 0.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers GT Biopharma (NASDAQ:GTBP) shares moved upwards by 6.6% to $0.65 durin...
12-06 05:05
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
HOLON, Israel, Oct. 27, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target di...
10-27 19:00
阿斯利康携四项重磅研究首发数据亮相ESMO，彰显重新定义癌症治疗的雄心
（来源：氨基观察） DESTINY-Breast11与DESTINY-Breast05两项研究入选主席研讨会（Presidential Symposium）...
10-15 12:05
Compugen Publishes Pooled Data Showing COM701 Activity in Platinum-Resistant Ovarian Cancer Ahead of ESMO Presentation
Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that pooled analysis of
10-13 19:10
Compugen to Present at SITC 2025
HOLON, Israel, Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...
10-06 19:00
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is ...
10-01 01:00
Compugen to Present Research at the Single Cell Genomics 2025 Conference
HOLON, ISRAEL, Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discover...
09-08 19:00
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
Compugen ( ($CGEN) ) has shared an update. On July 21, 2025, Compugen Ltd. anno...
07-21 19:28
